486 related articles for article (PubMed ID: 21992660)
21. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
Lee Y; Choi EH; Lee SW
Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
[TBL] [Abstract][Full Text] [Related]
22. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma.
Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK
Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194
[TBL] [Abstract][Full Text] [Related]
23. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling.
Vachiramon V; Sahawatwong S; Sirithanabadeekul P
Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554
[TBL] [Abstract][Full Text] [Related]
24. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
25. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.
Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH
J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814
[TBL] [Abstract][Full Text] [Related]
26. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
[TBL] [Abstract][Full Text] [Related]
28. Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.
Polnikorn N
J Cosmet Laser Ther; 2010 Jun; 12(3):126-31. PubMed ID: 20482238
[TBL] [Abstract][Full Text] [Related]
29. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients.
Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC
J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474
[TBL] [Abstract][Full Text] [Related]
30. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
31. Use of 532-nm Q-switched Nd:YAG laser for smoker's gingival hyperpigmentation.
Cho SB; Lee JH; Seo W; Bang D
J Cosmet Laser Ther; 2010 Apr; 12(2):77-80. PubMed ID: 20331344
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma.
Jang HW; Chun SH; Park HC; Ryu HJ; Kim IH
J Cosmet Laser Ther; 2017 Apr; 19(2):114-123. PubMed ID: 27911108
[TBL] [Abstract][Full Text] [Related]
33. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial.
Yun WJ; Moon HR; Lee MW; Choi JH; Chang SE
Dermatol Surg; 2014 Aug; 40(8):842-50. PubMed ID: 25022705
[TBL] [Abstract][Full Text] [Related]
34. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers.
Kauvar AN
Semin Cutan Med Surg; 2012 Jun; 31(2):126-32. PubMed ID: 22640433
[TBL] [Abstract][Full Text] [Related]
35. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
[TBL] [Abstract][Full Text] [Related]
36. Paradoxical darkening of unperceived tattoo ink after relatively low fluence from a Q-switched Nd:YAG (1064-nm) laser in the course of treatment for melasma.
Chung WK; Yang JH; Lee DW; Chang SE; Lee MW; Choi JH; Moon KC
Clin Exp Dermatol; 2009 Dec; 34(8):e555-7. PubMed ID: 19486060
[TBL] [Abstract][Full Text] [Related]
37. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment.
Park GH; Lee JH; Choi JR; Chang SE
J Dermatolog Treat; 2013 Aug; 24(4):297-9. PubMed ID: 22136311
[No Abstract] [Full Text] [Related]
38. New application of the long-pulsed Nd-YAG laser as an ablative resurfacing tool for skin rejuvenation: a 7-year study.
Alshami MA
J Cosmet Dermatol; 2013 Sep; 12(3):170-8. PubMed ID: 23992158
[TBL] [Abstract][Full Text] [Related]
39. Use of the Q-switched Nd:YAG laser for the treatment of pigmentary disorders in Egyptians.
Salem A; El Harras M; Ramadan A; Gamil H; Rahman AA; El-Said K
J Cosmet Laser Ther; 2010 Apr; 12(2):92-100. PubMed ID: 20331347
[TBL] [Abstract][Full Text] [Related]
40. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy.
Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
J Cosmet Laser Ther; 2015 Jun; 17(3):129-34. PubMed ID: 25415369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
